Oral Typhoid Vaccine to Witness High Growth Owing to its Ability to Protect Against Typhoid Bacteria


 The oral typhoid vaccine market is estimated to be valued at US$ 394.62Bn in 2023 and is expected to exhibit a CAGR of 12.% over the forecast period from 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Oral typhoid vaccines can provide effective protection against Salmonella Typhi bacteria, which causes typhoid fever. They are administered orally and are very easy to use. Typhoid fever remains a major public health challenge in many developing countries in Asia, Africa and Latin America. This market demand is driven by rising prevalence of the disease in these regions as well as increased awareness and affordability of oral typhoid vaccines.


Market Opportunity:

One of the major opportunities for growth in the oral typhoid vaccine market lies in increasing vaccination rates in developing countries where the disease burden is high. Typhoid fever is endemic in many parts of Asia, Africa and Latin America due to lack of access to clean water and sanitation facilities. Although vaccination is the most effective preventive measure against typhoid, the vaccination rates in these regions currently remain very low. For example,vaccination rates in South Asia are estimated to be under 10%. However, as healthcare access improves and awareness increases through government campaigns, more people are beginning to opt for typhoid vaccination. This represents a major opportunity for oral typhoid vaccine manufacturers to scale up supply and increase vaccination rates significantly in the coming years. With increased vaccination rates, the disease burden can potentially be reduced, opening avenues for further market demand.

Porter’s Analysis
Threat of new entrants: The threat is moderate as the oral typhoid vaccine market requires regulatory approvals and significant capital investments. However, the market is growing significantly providing opportunities.
Bargaining power of buyers: The power is high as buyers have several suppliers to choose from and focus on price and quality.
Bargaining power of suppliers: The power is moderate as major suppliers collaborate with buyers and focus on long-term supply contracts.
Threat of new substitutes: The threat is low as oral typhoid vaccines do not have close substitutes for typhoid disease prevention.
Competitive rivalry: The rivalry is high among existing market players focusing on new product launches, geographic expansions, and marketing campaigns.

SWOT Analysis
Strength: Wide product portfolios, strong brand recognitions, and global presence of key players. Established distribution networks provide easy access.
Weakness: High R&D and marketing costs to develop and commercialize new products. Regulatory compliance increases operational complexities and costs.
Opportunity: Increasing awareness, growing disease burden in developing nations, and supportive government policies drive market growth.
Threats: Pricing pressures, supply chain delays affect profitability. Emerging low-cost products from local manufacturers increase competition.

Key Takeaways
The global oral typhoid vaccine market is expected to witness high growth during the forecast period of 2023 to 2030.

Regional analysis shows that Asia pacific region dominates the market currently accounting for over 40% share due to high disease burden and presence of major generic manufacturers. The market in the region is projected to grow at fastest rate during the forecast period.

Key players operating in the oral typhoid vaccine market are Sanofi Pasteur, Bharat Biotech, Pfizer Inc., GlaxoSmithKline (GSK), Baxter International Inc., Merck & Co., Inc. (MSD outside North America), Takeda Pharmaceutical Company Limited, Novartis International AG, Biological E. Limited, AstraZeneca, Cipla Limited, Prokarium, Bio-Med Pvt. Ltd., Panacea Biotec, Dynavax Technologies Corporation, Butantan Institute, Zydus Cadila, Biomed Pvt. Ltd., Cadila Healthcare Limited, GlaxoSmithKline Biologicals.

Comments

Post a Comment

Popular posts from this blog

Unveiling Health Secrets: Exploring the Potential of Blood-Based Biomarkers

Image
  The human body is a complex and intricate system, often harboring subtle signs of its inner workings. One of the most promising avenues for unlocking these secrets lies within our bloodstream – a treasure trove of information encoded in the form of blood-based biomarkers. These biomarkers, measurable indicators present in the blood, hold the potential to revolutionize healthcare by providing early detection, accurate diagnosis, and personalized treatment approaches. Blood-based biomarkers encompass a wide range of molecules – from proteins and nucleic acids to metabolites and even circulating cells. Researchers have been diligently working to identify specific biomarkers associated with various diseases and conditions. For instance, elevated levels of certain proteins might point to cardiovascular diseases, while specific genetic material could indicate the presence of cancer. By analyzing these biomarkers, clinicians gain valuable insights into an individual's health status, en...
Read more

Revolutionizing Biology: Advancements in Single Cell Analysis Techniques

Image
  Single cell analysis has emerged as a groundbreaking technology that is revolutionizing the field of biology. Traditionally, biological studies were conducted on populations of cells, averaging out the heterogeneity present within them. However, the advent of single cell analysis has enabled scientists to delve into the complexity of individual cells, uncovering a wealth of previously inaccessible information. Advancements in single cell analysis techniques have paved the way for a deeper understanding of cellular heterogeneity, gene expression, and cellular behavior. One of the most remarkable techniques is single-cell RNA sequencing (scRNA-seq), which allows scientists to measure gene expression in individual cells. This breakthrough has led to the identification of rare cell types, understanding of cellular communication networks, and the discovery of novel biomarkers. Moreover, single cell imaging techniques, such as single cell fluorescence microscopy, have enabled research...
Read more

Medical Robots Market Poised to Grow Owing to Improving Healthcare Infrastructure

Image
 The Medical Robots Market is anticipated to witness robust growth due to rising healthcare spending across the globe. Medical robots are used to perform minimal invasive surgeries with greater accuracy and flexibility. Growing preference for Robot-Assisted Surgery (RAS) over conventional open surgeries due to benefits such as shorter recovery time and minimum operative scars has been augmenting demand for medical robots. Key functions include guiding and positioning surgical accessories like guide tubes in radiology and guiding catheter and wires in cardiology. With rising chronic disease prevalence associated with aging populations, the need for more surgical procedures is surging which requires precise action minimally invasive robotic systems can provide. The Global Medical Robots Market is estimated to be valued at US$ 11.47 Bn in 2024 and is expected to exhibit a CAGR of 16% over the forecast period 2023 to 2030. Key Takeaways: Key players operating in the Medical Robo...
Read more